Lexeo Therapeutics (LXEO) Common Equity: 2022
Historic Common Equity for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2022 value amounting to -$113.0 million.
- Lexeo Therapeutics' Common Equity fell 64.49% to -$162.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$162.8 million, marking a year-over-year decrease of 64.49%. This contributed to the annual value of -$113.0 million for FY2022, which is N/A change from last year.
- Per Lexeo Therapeutics' latest filing, its Common Equity stood at -$113.0 million for FY2022.
- In the past 5 years, Lexeo Therapeutics' Common Equity registered a high of -$113.0 million during FY2022, and its lowest value of -$113.0 million during FY2022.
- Its 1-year average for Common Equity is -$113.0 million, with a median of -$113.0 million in 2022.